Literature DB >> 508524

Altered pharmacokinetics of propranolol in hyperthyroidism [proceedings].

J Feely, J Crooks, I H Stevenson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508524     DOI: 10.1111/j.1365-2125.1979.tb04734.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

Review 1.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of beta-adrenoceptor blocking drugs in thyroid disease.

Authors:  J Feely
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

3.  Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Authors:  B Hallengren; O R Nilsson; B E Karlberg; A Melander; L Tegler; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Pharmacokinetics of propranolol and sotalol in hyperthyroidism.

Authors:  A Aro; M Anttila; T Korhonen; H Sundquist
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Influence of Carbimazole on Serum Levels and Haemodynamic Effects of Digoxin.

Authors:  B R Rao; G Petereit; U Ebert; W Kirch
Journal:  Clin Drug Investig       Date:  1997-06       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.